Patent · US Active

Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors

US8415341B2 · kind B2 · utility

13Cited by

0References

18Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Kristen Chevalier · Collegeville, US
Jose Clemente · West Chester, US
Scott L. Dax · Landenberg, US
Chris Flores · Spring House, US
Li Liu · Doylestown, US
Mark J. Macielag · Spring House, US
Mark McDonnell · Lansdale, US
Marina Nelen · Spring House, US
Erica Nulton · Spring House, US
Stephen Prouty · Philadelphia, US
Matthew Todd · Spring House, US
Sui-Po Zhang · Yeadon, US
Bin Zhu · Spring House, US

Key dates

Filing date	Apr 22, 2010
Grant date	Apr 9, 2013
Priority date	—
Expiry date	Nov 25, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for treating diseases, syndromes, conditions and disorders that are affected by the inhibition of MGL, including pain. Such compounds are represented by Formula (I) as follows:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.